Image

Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.

Description

The Priority Research Program and Equipment for Light-Matter (PEPR LUMA) has granted its support to the OpitcSkin project, which aims to provide diagnostic information that complements that currently provided by histology for the diagnosis of skin carcinomas, the most common cancers among fair-skinned populations. In recent years, several imaging and optical spectroscopy modalities have been evaluated in vivo in clinical settings to quantify the real-time diagnostic assistance they provide to clinicians performing surgical resection of skin carcinomas. Imaging methods such as confocal reflectance microscopy, optical coherence tomography, and nonlinear optical microscopy provide morphological information that improves diagnostic accuracy and reduces the risk of recurrence by allowing immediate verification after surgery that the tumor has been completely removed.

Spectroscopic methods, including Raman spectroscopy and autofluorescence, which are also applied in vivo, provide additional structural and functional information, for example on metabolism, further improving diagnostic accuracy. In all cases, studies have shown that combining multiple optical imaging and/or spectroscopy modalities, as well as data analysis and/or machine learning methods, offers better diagnostic accuracy than each modality taken individually.

Eligibility

Inclusion Criteria:

  • patients with skin carcinomas and actinic keratoses

Exclusion Criteria:

  • minor patient

Study details
    Skin Cancer
    Diagnostic

NCT07406022

Centre Hospitalier Régional Metz-Thionville

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.